Cite
Gut microbiota-derived tryptophan metabolites alleviate liver injury via AhR/Nrf2 activation in pyrrolizidine alkaloids-induced sinusoidal obstruction syndrome.
MLA
Shang, Haitao, et al. “Gut Microbiota-Derived Tryptophan Metabolites Alleviate Liver Injury via AhR/Nrf2 Activation in Pyrrolizidine Alkaloids-Induced Sinusoidal Obstruction Syndrome.” Cell & Bioscience, vol. 13, no. 1, July 2023, pp. 1–16. EBSCOhost, https://doi.org/10.1186/s13578-023-01078-4.
APA
Shang, H., Huang, C., Xiao, Z., Yang, P., Zhang, S., Hou, X., & Zhang, L. (2023). Gut microbiota-derived tryptophan metabolites alleviate liver injury via AhR/Nrf2 activation in pyrrolizidine alkaloids-induced sinusoidal obstruction syndrome. Cell & Bioscience, 13(1), 1–16. https://doi.org/10.1186/s13578-023-01078-4
Chicago
Shang, Haitao, Chao Huang, Zhuanglong Xiao, Pengcheng Yang, Shengyan Zhang, Xiaohua Hou, and Lei Zhang. 2023. “Gut Microbiota-Derived Tryptophan Metabolites Alleviate Liver Injury via AhR/Nrf2 Activation in Pyrrolizidine Alkaloids-Induced Sinusoidal Obstruction Syndrome.” Cell & Bioscience 13 (1): 1–16. doi:10.1186/s13578-023-01078-4.